Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy
Linhua Zhang, Shengjie Wu, Yu Qin, et al.
Nano Letters (2019) Vol. 19, Iss. 7, pp. 4237-4249
Closed Access | Times Cited: 172

Showing 26-50 of 172 citing articles:

The Role of Photodynamic Therapy in Triggering Cell Death and Facilitating Antitumor Immunology
Liuchang Tan, Xiaoxiao Shen, Zhiqiang He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 56
The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Xue Chen, Yunxiao Zhang, Yao Fu
Medicine in Drug Discovery (2022) Vol. 14, pp. 100122-100122
Open Access | Times Cited: 55
Lymph node-targeting nanovaccines for cancer immunotherapy
Qiu Wang, Zhe Wang, Xinxin Sun, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 102-122
Closed Access | Times Cited: 45
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 43
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
Xiaoxue Xie, Yi Feng, Hanxi Zhang, et al.
Bioactive Materials (2022) Vol. 16, pp. 107-119
Open Access | Times Cited: 42
Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination
Po-Yu Chou, Shyr‐Yi Lin, Yi‐No Wu, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 970-988
Closed Access | Times Cited: 40
Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics
Shama Parveen, Pratishtha Gupta, Saurabh Kumar, et al.
Medicine in Drug Discovery (2023) Vol. 20, pp. 100165-100165
Open Access | Times Cited: 36
Stimuli-Responsive Polymeric Nanovaccines Toward Next-Generation Immunotherapy
Liuzhou Mao, Panqin Ma, Xi Luo, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9826-9849
Closed Access | Times Cited: 35
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 33
Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy
Ao He, Xiaoye Li, Zhuo Dai, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 31
In Situ Polymerization-Mediated Antigen Presentation
Chao Pan, Lu Wang, Mengmeng Zhang, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 24, pp. 13261-13272
Closed Access | Times Cited: 29
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Nanovaccines: An effective therapeutic approach for cancer therapy
Sangiliyandi Gurunathan, Thangaraj Pratheep, Lin Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115992-115992
Open Access | Times Cited: 28
Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies
Haifen Luo, Wen Ma, Qi Chen, et al.
Nano Today (2023) Vol. 53, pp. 102042-102042
Closed Access | Times Cited: 23
Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer
Chenlu Huang, Hanyong Wang, Xinyu Yang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 29
Closed Access | Times Cited: 15
Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery
Suhair Sunoqrot, Sara A. Abdel Gaber, Razan Abujaber, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 4998-5019
Closed Access | Times Cited: 13
Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics
Iman Zare, Shahrzad Zirak Hassan Kiadeh, Ayşegül Varol, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 158-178
Closed Access | Times Cited: 12
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Shuyan Han, Keqing Huang, Zhipeng Gu, et al.
Nanoscale (2019) Vol. 12, Iss. 2, pp. 413-436
Closed Access | Times Cited: 58
Emerging nanomedicines for effective breast cancer immunotherapy
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 58
Engineering nanoparticulate vaccines for enhancing antigen cross-presentation
Guangsheng Du, Xun Sun
Current Opinion in Biotechnology (2020) Vol. 66, pp. 113-122
Closed Access | Times Cited: 57
Hepatocellular Carcinoma Growth Retardation and PD-1 Blockade Therapy Potentiation with Synthetic High-density Lipoprotein
Junyang Wang, Meng Jia, Ran Wei, et al.
Nano Letters (2019) Vol. 19, Iss. 8, pp. 5266-5276
Closed Access | Times Cited: 56
Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses
Yingying Hou, Ying Wang, Yao Tang, et al.
Journal of Controlled Release (2020) Vol. 326, pp. 120-130
Closed Access | Times Cited: 53
Nanovaccines integrating endogenous antigens and pathogenic adjuvants elicit potent antitumor immunity
Min Li, Han Zhou, Wei Jiang, et al.
Nano Today (2020) Vol. 35, pp. 101007-101007
Closed Access | Times Cited: 53

Scroll to top